e8vk
Table of Contents



SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of earliest event reported: January 12, 2004


     
Select Medical Corporation

(Exact name of registrant as specified in charter)
         
Delaware   000-32499   23-2872718
(State of Incorporation)   (Commission File Number)   (I.R.S. Employer
        Identification No.)
     
4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055

(Address of Principal Executive Offices) (Zip Code)
     
(717) 972-1100

(Registrant’s telephone number, including area code)



 


TABLE OF CONTENTS

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
Item 9. Regulation FD Disclosure.
SIGNATURE
EXHIBIT INDEX
INVESTOR PRESENTATION, JANUARY 2004.


Table of Contents

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

  (c)   Exhibits
             
   
99.1

  Select Medical Corporation Investor Presentation dated January 2004.

Item 9. Regulation FD Disclosure.

        Attached as exhibit 99.1 and furnished for purposes of Regulation FD is an Investor Presentation that will be given by Select Medical Corporation at the JPMorgan 22nd Annual Healthcare Conference to be held January 12-15, 2004.

        The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 9 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

 


Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

         
    SELECT MEDICAL CORPORATION
         
Date: January 9, 2004   By:   /s/ Michael E. Tarvin
       
        Michael E. Tarvin
Senior Vice President, General Counsel
and Secretary

 


Table of Contents

EXHIBIT INDEX

     
Exhibit No.   Description

 
99.1   Select Medical Corporation Investor Presentation dated January 2004.